• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年特应性皮炎发病、复发和持续的预测:一项前瞻性队列研究。

Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study.

机构信息

Unit for Occupational and Environmental Epidemiology and Net Teaching, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich LMU, Munich, Germany.

出版信息

J Allergy Clin Immunol. 2010 Sep;126(3):590-5.e1-3. doi: 10.1016/j.jaci.2010.06.020.

DOI:10.1016/j.jaci.2010.06.020
PMID:20816192
Abstract

BACKGROUND

Although it is known that atopic dermatitis (AD) can develop during adolescence, research on its course and predictors in this age group is thus far limited.

OBJECTIVE

We aimed to describe the course of AD over puberty and prospectively determine risk factors for the incidence, recurrence, and persistence of AD until adolescence in a population-based cohort study.

METHODS

German participants of the International Study of Asthma and Allergies in Childhood Phase II were followed prospectively. The final dataset comprised 2857 adolescents, of whom 2433 were unaffected by AD at baseline. Bivariate and multivariate prediction models for the incidence, recurrence, and persistence of AD using early-life factors, family history of atopic diseases, and job history as predictors were developed.

RESULTS

The incidence of AD between ages 9 to 11 and 16 to 20 years was 1.7%, and recurrence was 2.4%. AD persisted in 47.6% of adolescents with AD symptoms at baseline (n = 424). High socioeconomic status, female sex, asthma symptoms and a positive skin prick test response at baseline, parental history of rhinitis/AD, and having worked in a high-risk job were significant predictors for the course of disease. With all the factors present, the probability of the incidence of AD was 21.4% (95% CI, 1.8% to 80.2%) and increased up to 81.7% (95% CI, 47.0% to 95.8%) for recurrence of AD and 87.6% (95% CI, 63.4% to 96.6%) for persistence of AD among those affected by AD. Early-life exposures did not predict the course of AD over puberty.

CONCLUSION

Genetic factors, early allergen sensitization, and having worked in a high-risk job seem to be more important for disease development in late adolescence than other early-life exposures.

摘要

背景

尽管已知特应性皮炎(AD)可在青春期发生,但目前针对该年龄段 AD 病程及其预测因素的研究仍十分有限。

目的

我们旨在描述青春期 AD 的病程,并在一项基于人群的队列研究中前瞻性确定 AD 在青春期前发病、复发和持续的风险因素。

方法

德国国际儿童哮喘和过敏研究 II 期参与者进行前瞻性随访。最终数据集包含 2857 名青少年,其中 2433 名基线时无 AD。采用生命早期因素、特应性疾病家族史和职业史作为预测因素,建立用于预测 AD 发病、复发和持续的双变量和多变量预测模型。

结果

9 至 11 岁和 16 至 20 岁之间 AD 的发病率为 1.7%,复发率为 2.4%。在基线时有 AD 症状的青少年中,47.6%(n=424)AD 持续存在。高社会经济地位、女性、哮喘症状和基线时皮肤点刺试验阳性反应、父母有鼻炎/AD 病史以及从事高风险职业,是疾病病程的显著预测因素。在所有因素存在的情况下,AD 发病的概率为 21.4%(95%CI,1.8%至 80.2%),AD 复发的概率增加至 81.7%(95%CI,47.0%至 95.8%),AD 持续的概率增加至 87.6%(95%CI,63.4%至 96.6%)。生命早期暴露因素不能预测青春期 AD 的病程。

结论

遗传因素、早期变应原致敏和从事高风险职业,似乎比其他生命早期暴露因素对青少年晚期疾病的发生发展更为重要。

相似文献

1
Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study.青少年特应性皮炎发病、复发和持续的预测:一项前瞻性队列研究。
J Allergy Clin Immunol. 2010 Sep;126(3):590-5.e1-3. doi: 10.1016/j.jaci.2010.06.020.
2
Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children.生命最初3年特应性皮炎的发生情况:哥本哈根儿童哮喘前瞻性研究中的高危儿童队列研究
Arch Dermatol. 2006 May;142(5):561-6. doi: 10.1001/archderm.142.5.561.
3
Prediction of the incidence and persistence of allergic rhinitis in adolescence: a prospective cohort study.青少年变应性鼻炎发病和持续情况的预测:一项前瞻性队列研究。
J Allergy Clin Immunol. 2012 Feb;129(2):397-402, 402.e1-3. doi: 10.1016/j.jaci.2011.08.016. Epub 2011 Sep 15.
4
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma.特应性皮炎从出生到7岁的自然病程及其与哮喘的关联。
J Allergy Clin Immunol. 2004 May;113(5):925-31. doi: 10.1016/j.jaci.2004.01.778.
5
Epidemiology of atopic dermatitis and atopic march in children.儿童特应性皮炎和特应性进程的流行病学。
Immunol Allergy Clin North Am. 2010 Aug;30(3):269-80. doi: 10.1016/j.iac.2010.06.003.
6
Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.儿童过敏性疾病的预防:一级和二级过敏预防的临床与流行病学方面
Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x.
7
Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study.母乳喂养、母乳中可溶性CD14浓度与儿童早期特应性皮炎和哮喘风险:出生队列研究
Clin Exp Allergy. 2005 Aug;35(8):1014-21. doi: 10.1111/j.1365-2222.2005.02298.x.
8
Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors.特应性皮炎高危队列:自然病史、相关过敏结局和危险因素。
Ann Allergy Asthma Immunol. 2013 Jan;110(1):24-8. doi: 10.1016/j.anai.2012.10.005. Epub 2012 Nov 8.
9
Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age.新西兰3.5岁儿童特应性皮炎的风险因素。
Br J Dermatol. 2005 Apr;152(4):742-9. doi: 10.1111/j.1365-2133.2005.06540.x.
10
Development of atopic dermatitis in the DARC birth cohort.特应性皮炎在 DARC 出生队列中的发展。
Pediatr Allergy Immunol. 2010 Mar;21(2 Pt 1):307-14. doi: 10.1111/j.1399-3038.2009.00914.x. Epub 2009 Sep 24.

引用本文的文献

1
TSLP: contrasting roles in cancer.胸腺基质淋巴细胞生成素(TSLP):在癌症中的相反作用
Front Immunol. 2025 Aug 12;16:1627235. doi: 10.3389/fimmu.2025.1627235. eCollection 2025.
2
Evaluating a School-Based Public Health Intervention for Self-Management in Children with Atopic Dermatitis: A Non-Randomized Controlled Study.评估一项针对特应性皮炎儿童自我管理的校本公共卫生干预措施:一项非随机对照研究。
Children (Basel). 2025 May 24;12(6):676. doi: 10.3390/children12060676.
3
A multidimensional analysis of prognostic factors in atopic dermatitis.
特应性皮炎预后因素的多维分析。
Front Med (Lausanne). 2025 Apr 17;12:1554669. doi: 10.3389/fmed.2025.1554669. eCollection 2025.
4
Disease modification in inflammatory skin disorders: opportunities and challenges.炎症性皮肤疾病的疾病修饰:机遇与挑战。
Nat Rev Drug Discov. 2023 Aug;22(8):662-680. doi: 10.1038/s41573-023-00735-0. Epub 2023 Jul 13.
5
Atopic Dermatitis: Disease Features, Therapeutic Options, and a Multidisciplinary Approach.特应性皮炎:疾病特征、治疗选择及多学科方法
Life (Basel). 2023 Jun 20;13(6):1419. doi: 10.3390/life13061419.
6
Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international survey.AWARE 1中成年特应性皮炎患者的流行病学:第二项国际调查
World Allergy Organ J. 2023 Mar 28;16(3):100724. doi: 10.1016/j.waojou.2022.100724. eCollection 2023 Mar.
7
Antibody-Mediated Delivery of VEGF-C Promotes Long-Lasting Lymphatic Expansion That Reduces Recurrent Inflammation.抗体介导的 VEGF-C 递送促进持久的淋巴管扩张,减少炎症复发。
Cells. 2022 Dec 31;12(1):172. doi: 10.3390/cells12010172.
8
Lindley Administration Attenuates Atopic Dermatitis-like Lesions by Modulating Immune Cells.林德利管理通过调节免疫细胞来减轻特应性皮炎样病变。
Int J Mol Sci. 2022 Apr 18;23(8):4470. doi: 10.3390/ijms23084470.
9
The Epidemiology and Global Burden of Atopic Dermatitis: A Narrative Review.特应性皮炎的流行病学与全球负担:一项叙述性综述
Life (Basel). 2021 Sep 9;11(9):936. doi: 10.3390/life11090936.
10
The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the Global Burden of Disease Study 2017.195个国家和地区特应性皮炎的全球、区域和国家负担:一项来自2017年全球疾病负担研究的生态学研究
JAAD Int. 2020 Nov 30;2:12-18. doi: 10.1016/j.jdin.2020.10.002. eCollection 2021 Mar.